Carvedilol tablets are an alpha/beta-adrenergic blocking agent indicated for the treatment of: mild to severe chronic heart failure left ventricular dysfunction following myocardial infarction in clinically stable patients hypertension 1.1 Heart Failure Carvedilol tablets are indicated for the treatment of mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin, usually in addition to diuretics, ACE inhibitors, and digitalis, to increase survival and, also, to reduce the risk of hospitalization.
From the U.S. FDA-approved label for Carvedilol. Full label: DailyMed.
Carvedilol tablets are an alpha/beta-adrenergic blocking agent indicated for the treatment of: mild to severe chronic heart failure left ventricular dysfunction following myocardial infarction in clinically stable patients hypertension 1.1 Heart Failure Carvedilol tablets are indicated for the treatment of mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin, usually in addition to diuretics, ACE inhibitors, and digitalis, to increase survival and, also, to reduce the risk of hospitalization. 1.2 Left Ventricular Dysfunction following Myocardial Infarction Carvedilol tablets are indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of less than or equal to 40% (with or without symptomatic heart failure). 1.3 Hypertension Carvedilol tablets are indicated for the management of essential hypertension. It can be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics.
From the U.S. FDA-approved label for Carvedilol. Full label: DailyMed.
Take with food. Individualize dosage and monitor during up-titration. Heart failure: Start at 3.125 mg twice daily and increase to 6.25, 12.5, and then 25 mg twice daily over intervals of at least 2 weeks.
Directions from the U.S. FDA-approved label for Carvedilol — your doctor or pharmacist may advise differently.
Bronchial asthma or related bronchospastic conditions. Second- or third-degree AV block. Sick sinus syndrome. Severe bradycardia (unless permanent pacemaker in place). Patients in cardiogenic shock or decompensated heart failure requiring the use of IV inotropic therapy. Severe hepatic impairment. History of serious hypersensitivity reaction (e.g., Stevens-Johnson syndrome, anaphylactic reaction, angioedema) to any component of this medication or other medications containing carvedilol.
Excerpt from the U.S. FDA-approved label for Carvedilol. Talk to a pharmacist or doctor before use.
Acute exacerbation of coronary artery disease upon cessation of therapy: Do not abruptly discontinue. Bradycardia, hypotension, worsening heart failure/fluid retention may occur. Reduce the dose as needed. Non-allergic bronchospasm (e.g., chronic bronchitis and emphysema): Avoid β-blockers. However, if deemed necessary, use with caution and at lowest effective dose. Diabetes: May mask symptoms of hypoglycemia and alter glucose levels; monitor 5.1 Cessation of Therapy Patients with coronary artery disease, who are being treated with carvedilol tablets, should be advised against abrupt discontinuation of therapy.
Warnings and precautions excerpt from the U.S. FDA-approved label for Carvedilol — not a complete list. Talk to a pharmacist or doctor before use.
Most common adverse events: Heart failure and left ventricular dysfunction following myocardial infarction (≥10%): Dizziness, fatigue, hypotension, diarrhea, hyperglycemia, asthenia, bradycardia, weight increase. Hypertension (≥5%): Dizziness. To report SUSPECTED ADVERSE REACTIONS, contact Zydus Pharmaceuticals (USA) Inc. at 1- 877-993-8779 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Excerpt from the U.S. FDA-approved label for Carvedilol — not a complete list. Talk to a pharmacist or doctor about side effects.
17 brands · 6 makers in the NepalDoc catalog — see the full Carvedilol guide →
Storage Store at 20°C to 25°C (68°F to 77°F). Protect from moisture.
Storage information from the U.S. FDA-approved label for Carvedilol.
What is Vidol 3.125?
Vidol 3.125mg Tablet is a Carvedilol medicine made by Quest Pharmaceuticals Pvt. Ltd. It comes as 3.125mg Tablet.
What is the generic name of Vidol 3.125?
The generic name of Vidol 3.125 is Carvedilol.
Which brands of Carvedilol are available in Nepal?
17 brands of Carvedilol are listed in the NepalDoc catalog, from 6 makers — including Carca 3.125mg Tablet, Carca 6.25mg Tablet, Carca 12.5mg Tablet, Carca 25mg Tablet, Cardivas 3.125mg Tablet, Cardivas 6.25mg Tablet.
What are the side effects of Carvedilol?
Most common adverse events: Heart failure and left ventricular dysfunction following myocardial infarction (≥10%): Dizziness, fatigue, hypotension, diarrhea, hyperglycemia, asthenia, bradycardia, weight increase.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
Every NepalDoc section, one tap away.
Find doctors by specialty across Nepal.
